ANX007
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ANX007, covering 2024-08-21 to 2024-08-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy [Phase 2]